G
Gilbert Kokwaro
Researcher at Wellcome Trust
Publications - 87
Citations - 3765
Gilbert Kokwaro is an academic researcher from Wellcome Trust. The author has contributed to research in topics: Malaria & Population. The author has an hindex of 29, co-authored 84 publications receiving 3547 citations. Previous affiliations of Gilbert Kokwaro include Cardiff University & University of Liverpool.
Papers
More filters
Journal ArticleDOI
Averting a malaria disaster.
Nicholas J. White,François Nosten,Sornchai Looareesuwan,William M. Watkins,Kevin Marsh,Robert W. Snow,Gilbert Kokwaro,John H. Ouma,Tran Tinh Hien,Malcolm E. Molyneux,Malcolm E. Molyneux,Terrie E. Taylor,Terrie E. Taylor,Chris I. Newbold,TK Ruebush,M Danis,Brian Greenwood,Roy M. Anderson,Piero Olliaro +18 more
TL;DR: Pyrimethamine-sulphadoxine (PSD) is usually deployed as a successor to chloroquine, but resistance to PSD is increasing and a health calamity looms within the next few years.
Journal ArticleDOI
Genome-wide and fine-resolution association analysis of malaria in West Africa
Muminatou Jallow,Yik Ying Teo,Yik Ying Teo,Kerrin S. Small,Kerrin S. Small,Kirk A. Rockett,Kirk A. Rockett,Panos Deloukas,Taane G. Clark,Taane G. Clark,Katja Kivinen,Kalifa Bojang,David J. Conway,Margaret Pinder,Giorgio Sirugo,Fatou Sisay-Joof,Stanley Usen,Sarah Auburn,Sarah Auburn,Suzannah Bumpstead,Susana Campino,Susana Campino,Alison J. Coffey,Andrew Dunham,Andrew E. Fry,Angela Green,Rhian Gwilliam,Sarah E. Hunt,Michael Inouye,Anna E. Jeffreys,Alieu Mendy,Aarno Palotie,Simon C. Potter,Jiannis Ragoussis,Jane Rogers,Kate Rowlands,Elilan Somaskantharajah,Pamela Whittaker,Claire Widden,Peter Donnelly,Bryan Howie,Jonathan Marchini,Andrew P. Morris,Miguel A. Sanjoaquin,Miguel A. Sanjoaquin,Eric A. Achidi,Tsiri Agbenyega,Angela Allen,Angela Allen,Olukemi K. Amodu,Patrick H. Corran,Abdoulaye A. Djimde,Amagana Dolo,Ogobara K. Doumbo,Chris Drakeley,Sarah J. Dunstan,Jennifer Evans,Jennifer Evans,Jeremy Farrar,Deepika Fernando,Tran Tinh Hien,Rolf D. Horstmann,Muntaser E. Ibrahim,Nadira D. Karunaweera,Gilbert Kokwaro,Kwadwo A. Koram,Martha M. Lemnge,Julie Makani,Kevin Marsh,Pascal Michon,David Modiano,Malcolm E. Molyneux,Ivo Mueller,Michael Parker,Norbert Peshu,Christopher V. Plowe,Odile Puijalon,John C. Reeder,Hugh Reyburn,Eleanor M. Riley,Anavaj Sakuntabhai,Pratap Singhasivanon,Sodiomon B. Sirima,Adama Tall,Terrie E. Taylor,Mahamadou A. Thera,Marita Troye-Blomberg,Thomas N. Williams,Michael T. Wilson,Dominic P. Kwiatkowski,Dominic P. Kwiatkowski +90 more
TL;DR: These findings provide proof of principle that fine-resolution multipoint imputation, based on population-specific sequencing data, can substantially boost authentic GWA signals and enable fine mapping of causal variants in African populations.
Journal ArticleDOI
WHO, the Global Fund, and medical malpractice in malaria treatment
Amir Attaran,Karen I. Barnes,C. F. Curtis,Umberto D'Alessandro,Caterina I. Fanello,Mary R. Galinski,Gilbert Kokwaro,Sornchai Looareesuwan,Michael Makanga,Theonest K. Mutabingwa,Ambrose Talisuna,Jean-François Trape,William M. Watkins +12 more
TL;DR: Amir Attaran and colleagues highlight a very serious public-health issue: provision of ineffective drugs for a life-threatening disease is indefensible and the donors must take some responsibility for this failure.
Journal ArticleDOI
Strengthening capacity for health research in Africa
James A. G. Whitworth,Gilbert Kokwaro,Samson M. Kinyanjui,Valerie A. Snewin,Marcel Tanner,Mark Walport,Nelson K. Sewankambo +6 more
TL;DR: Significant challenges remain for sub-Saharan Africa to establish a common framework for sustainable research capacity strengthening, including those supported by WHO and Tropical Disease Research.
Journal ArticleDOI
Chloroquine resistance before and after its withdrawal in Kenya
Leah Mwai,Leah Mwai,Edwin Ochong,Abdi Abdirahman,Steven M. Kiara,Steve A. Ward,Gilbert Kokwaro,Philip Sasi,Kevin Marsh,Kevin Marsh,Steffen Borrmann,Steffen Borrmann,Margaret J. Mackinnon,Margaret J. Mackinnon,Alexis Nzila +14 more
TL;DR: CQ resistance was declining before the drug's official withdrawal, suggesting that, prior to the official ban, the use of CQ had decreased, probably due to its poor clinical effectiveness.